Aphea.Bio
PrivateLast Round
Grant
Sep 16, 2025
Total Funding Raised
$131.93M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aphea.Bio is an agricultural biotechnology company that develops microorganism-based biostimulants and biocontrol products to enhance crop yields and health while promoting sustainable agricultural practices.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aphea.Bio Comparables
Compare Aphea.Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioConsortia, Inc. | 83% | |
| Fyteko | 83% | |
| Evologic Technologies | 79% | |
Aphea.Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 16, 2025 | ||||
| Grant | Nov 4, 2024 | ||||
| Series C | Jul 11, 2023 | ||||
| Series B | Apr 14, 2021 | ||||
| Series B | Nov 20, 2020 | ||||
Series A | Jun 26, 2017 |
Key People
Founding team and executive leadership
Aphea.Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series C |
| Sopartec | Series B, Series A |
| KU Leuven Research & Development (LRD) | Series B |
| Astanor Ventures | Series C, Series B |
| Korys | Series C |
| KU Leuven | Series A |
| V-Bio Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 147% MoM.
- Sep 16, 2025
Received funding from VLAIO Team Business Trajectories.
Aphea.Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aphea.Bio's valuation, stock price, and market status.